11 June 2026
ARCS has announced it is now LifeSciences Australia, with the name change part of a strategic push to better support professionals across the expanding life sciences sector.
26 May 2026
ARCS Australia Ltd has launched the ARCS Public Clinical Site Partnership, a new national model designed to strengthen the capability, visibility and sector connection of public clinical research sites across Australia. Monash Health has joined as a founding partner.
Read More
22 May 2026
ARCS Australia has welcomed the release of the Australian Government’s National Health and Medical Research Strategy 2026–2036, describing it as an important step towards a more coordinated, capable and impact-focused health and medical research system.
Read More
07 January 2026
ARCS Australia has submitted its 2026–27 Federal Pre-Budget Submission, calling on Government to ensure that investment in Australia’s clinical trials system is matched by targeted and sustained investment in workforce capability.
Read More
19 November 2025
ARCS Australia has released a new white paper, Strengthening Australia’s Clinical Trials Workforce: ARCS Clinical Research Workforce Capacity Summit Insights and Strategic Blueprint. The report brings together insights from across government, health services, universities, industry and the clinical workforce to outline practical steps for building a sustainable, skilled and nationally coordinated clinical trials workforce in Australia. This work is designed to support Australia’s ambition to remain a leading destination for clinical trials, improve access to innovative therapies for patients, and ensure the workforce is recognised, supported and prepared for future growth
Read More19 September 2025
ARCS Australia is pleased to announce the appointment of two highly respected leaders in the Australian Lifesciences sector, Anne O’Neill PSM MMPP and Associate Professor Tam Nguyen FMPP, following the recent board election.
Read More
22 July 2025
ARCS Australia and Macquarie University have announced a new partnership to deliver the inaugural Clinical Research Workforce Capability and Capacity Summit, to be held at Macquarie University on 2 September 2025. This national Summit will address the urgent and growing need to build a sustainable, future-ready workforce for clinical research in Australia—an essential foundation for the country’s ability to conduct world-class research, attract global trials, and ensure timely access to innovative therapies.
Read More
03 July 2025
The MedTech and Pharmaceutical (MTP) Sector Awards celebrates individuals each year who have made significant contributions to the sector. Nominees can come from any occupation within the sector including Regulatory Affairs, Clinical Research, Pharmacovigilance, Medical Affairs/Operations/Information, GMP, Quality, Health Economics etc, and nominees must be an ARCS Australia Professional member. Members are recognised for their contributions to the profession's advancement, dedicated service, mentorship, strong leadership, or as rising leaders.
Read More
31 March 2025
ARCS Australia Ltd, the peak body representing life sciences professionals in the medtech and pharmaceutical sectors, strongly supports the release of the NSW Innovation Blueprint 2035. The Blueprint outlines a long-term, strategic vision for NSW as a global leader in innovation and recognises the critical role of the life sciences sector in delivering health, economic and social benefits. With a focus on advanced manufacturing, clinical trials, vaccine technologies, and commercialisation, the Blueprint aligns closely with ARCS Australia's mission to build workforce capability and support the growth of innovative businesses across the therapeutic goods sector.
Read More
27 March 2025
ARCS Australia welcomes the 2025–26 Federal Budget and acknowledges its implications for our members working to advance innovation in healthcare across the medtech and pharmaceutical sectors.
Read More18 June 2024
On 22 November 2023, ARCS orchestrated a pivotal summit focusing on the ICH-GCP E6(R3) renovation, emphasising the power of collaboration for successful implementation.
Read More13 June 2024
ARCS is proud to launch a comprehensive Core Competency Framework tailored for the Medtech and Pharmaceutical sectors.
Read More02 May 2024
ARCS Australia is delighted to endorse the Australian Government's new initiative, the National One Stop Shop for clinical trials, announced today by the Minister for Health and Aged Care, the Hon Mark Butler MP.
Read More24 April 2024
On April 23, 2024, the ARCS Australia conducted a highly anticipated free Health Economics Interest Area Webinar. Featuring Medicines Australia CEO, Elizabeth De Somer.
Read More03 April 2024
Talking HealthTech is proud to be an official media partner for the 2024 ARCS Annual Conference.
Read More26 March 2024
ARCS Australia Ltd, the peak organisation dedicated to the advancement of professionals in the MedTech, Biotech and Pharmaceutical sector, is thrilled to announce the inaugural BioBeacon event, set to take place on 14 June 2024 at ICC Sydney.
Read More
18 March 2021
MTPConnect today announced its selection of industry training providers to deliver new programs addressing key skills gaps in the medical technology, biotechnology and pharmaceutical (MTP) sector workforce.
Read More
04 August 2020
A leading group of Contract Research Organisations (CROs) under the leadership of ARCS Australia are calling on the federal government to improve policies and processes around national coordination of clinical trials in Australia.
Read More
05 August 2019
Close to 1200 professionals from the healthcare sector will gather in Sydney tomorrow to attend the three-day ARCS 2019 annual conference on Putting patients at the centre of healthcare.
Read More
09 May 2019
Industry is a key driver of better health outcomes in our health system, and industry-driven research and development (R&D) activities are critical to achieve this.
Read More